INBS
Intelligent Bio Solutions Inc.
NASDAQ: INBS · HEALTHCARE · MEDICAL DEVICES
$1.76
-3.83% today
Updated 2026-10-30
Market cap
$5.27M
P/E ratio
—
P/S ratio
1.25x
EPS (TTM)
$-8.44
Dividend yield
—
52W range
$1 – $25
Volume
0.2M
Intelligent Bio Solutions Inc. (INBS) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$1.76
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$4.27
Financial forecast
| Metric | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -294.90%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.